Table II.
Patient characteristics.
| Characteristics | Standard regimen group (n=54) | Aprepitant regimen group (n=59) | Comparison test |
|---|---|---|---|
| Age, mean years ± SD | 63.48±10.23 | 66.46±9.81 | n.s.a |
| Gender (male/female) | 30/24 | 34/25 | n.s. |
| Smoking (no/yes) | 41/12 | 44/15 | n.s. |
| Alcoholic drinks/week | |||
| 0/1/2–3/>4 | 34/3/3/14 | 34/6/10/8 | n.s. |
| History of motion sickness | |||
| (no/yes) | 47/7 | 49/10 | n.s. |
| Chemotherapy regimen | |||
| (FOLFOX/FOLFIRI/XEROX) | 25/3/26 | 19/3/37 | n.s. |
| 5-HT3 RAs | |||
| Granisetron/ondansetron | 17/4/8/25 | 13/2/7/37 | n.s. |
| Azasetron/palonosetron |
a
t-test, others: χ2 test. SD, standard deviation; n.s., not significant.